| Application no. and date | 15821589.7 (espacenet) (Federated) (European Patent Register), 20150716 | | Patent/reg. no. and date | DK/EP 3169345, 20250129 | | Publication date | 20170524 | | Priority no. and date | US 201462025737 P, 20140717 | | EP pub. no. and date |
EP 3169345 20170524 | | Effective date | | | Applicant/owner | Melinta Therapeutics, LLC, 389 Interpace Parkway
Suite 450
Parsippany, NJ 07054, US | | Applicant ref. no. | | | Inventor | RAFAI FAR, Adel, 2170 Hanover Road
Mount-Royal, Québec H3R 2X8, CA,
KRISHNA, Gopal, c/o The Medicines Company
8 Sylvan Way
Parsippany, New Jersey 07054, US,
DING, Min, c/o The Medicines Company
8 Sylvan Way
Parsippany, New Jersey 07054, US,
CHEMBURKAR, Sanjay R., c/o AbbVie Inc.
1 North Waukegan Road
Building AP-34-2
North Chicago, Illinois 60064, US,
KNABLE, Carl M., c/o AbbVie Inc.
1 North Waukegan Road
Building AP-34-2
North Chicago, Illinois 60064, US,
PRUYNE, Julie J., c/o AbbVie Inc.
1 North Waukegan Road
Building AP-34-2
North Chicago, Illinois 60064, US,
REAMER, Douglas M., c/o AbbVie Inc.
1 North Waukegan Road
Building AP-34-2
North Chicago, Illinois 60064, US,
PETZEL, James P., c/o AbbVie Inc.
1 North Waukegan Road
Building AP-34-2
North Chicago, Illinois 60064, US | | Representative | | | Opponent | | | IPC Class | A61K 31/7052 (2006.01) , A61K 38/14 (2006.01) , A61K 47/26 (2006.01) , A61K 47/30 (2006.01) , A61K 47/36 (2006.01) , A61K 9/19 (2006.01) , A61P 31/04 (2006.01) , C07K 9/00 (2006.01) , C12P 21/02 (2006.01) | | Title | HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME | | Int. application no. | US2015040736 | | Int. publication no. | WO2016011245 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
